CTRI/2019/04/018732暂停2 期
A pharmaceutico clinical study of new dosage forms of rasnasaptak kwatha in amavata
parul ayurved pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 暂停
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •classical features of amavata, newly diagnosed patients (symptoms duration must be less than 1 year
排除标准
- •having diseases like cardiac diseases, tuberculosis, diabetes mellitus, hypertension, HIV,
- •having severe crippling deformity
研究者
相似试验
进行中（未招募）
不适用
A Dose-ranging, Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less Than 6 Years of Age: A 4-week, Multicenter, Randomized, Double-Blind Study with a 1-year Open-label, Follow-up Period.Hypertension in children under the age of 6 yearsEUCTR2004-004264-75-BEAstraZeneca Pharmaceuticals125
进行中（未招募）
1 期
A Dose-ranging, Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less Than 6 Years of Age: A 4-week, Multicenter, Randomized, Double-Blind Study with a 1-year Open-label, Follow-up Period.Hypertension in children under the age of 6 yearsEUCTR2004-004264-75-GBAstraZeneca AB93
进行中（未招募）
不适用
A Dose-ranging, Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less Than 6 Years of Age: A 4-week, Multicenter, Randomized, Double-Blind Study with a 1-year Open-label, Follow-up Period.EUCTR2004-004264-75-DEAstraZeneca AB125
进行中（未招募）
不适用
A Dose-ranging, Safety and Pharmacokinetics Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects 1 to Less Than 6 Years of Age: A 4-week, Multicenter, Randomized, Double-Blind Study with a 1-year Open-label, Follow-up Period.Hypertension in children under the age of 6 yearsEUCTR2004-004264-75-DKAstraZeneca Pharmaceuticals125
进行中（未招募）
1 期
Study to Investigate the product Wilate in Patients with Severe Hemophilia ASevere hemophilia A (<1% FVIII:C)MedDRA version: 20.0Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-003681-34-PLOctapharma AG55